Cargando…

A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols.

To test the feasibility of employing a combined lung adenoma/skin papilloma assay for broader detection of chemical carcinogenesis than that realized with either bioassay done separately, four strains of mice, SENCAR, BALB/c, A/J, and ICR-Swiss, were administered carcinogens either by the oral or in...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, M, Bull, R J, Knutsen, G L, Shields, R P, Stober, J
Formato: Texto
Lenguaje:English
Publicado: 1986
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1474240/
https://www.ncbi.nlm.nih.gov/pubmed/3780626
_version_ 1782127865998868480
author Robinson, M
Bull, R J
Knutsen, G L
Shields, R P
Stober, J
author_facet Robinson, M
Bull, R J
Knutsen, G L
Shields, R P
Stober, J
author_sort Robinson, M
collection PubMed
description To test the feasibility of employing a combined lung adenoma/skin papilloma assay for broader detection of chemical carcinogenesis than that realized with either bioassay done separately, four strains of mice, SENCAR, BALB/c, A/J, and ICR-Swiss, were administered carcinogens either by the oral or intraperitoneal (IP) routes. The carcinogens administered were ethyl carbamate (EC), benzo(a)pyrene [B(a)P], N-[4-(5-nitro-2-furyl)thiazolyl]formamide (FANFT), and acrylamide (ACR). Starting 2 weeks later, 1 to 5 micrograms (depending on strain) of 12-O-tetradecanoylphorbol-13-acetate (TPA) in 0.2 mL acetone/mouse was applied three times weekly to the shaved back for 20 weeks. All strains displayed increases in the yield of lung adenomas in response to EC at 32 weeks. B(a)P increased lung adenomas in only the SENCAR and A/J strain. Only the SENCAR and ICR-Swiss mice gave positive responses in the skin. In the SENCAR mice, positive response was seen with all four chemicals, however, FANFT gave an inconsistent response. The ICR-Swiss mice responded with an increased skin papilloma yield only to EC. In a separate experiment involving only SENCAR mice, animals were treated with a single oral dose of diethylnitrosamine (DEN) followed by triweekly application of 1.0 microgram TPA. This treatment resulted in 51/57 animals developing lung adenomas vs. 5/57 in the control animals. No treatment-related skin tumors resulted with DEN. Histopathologically confirmed lesions indicate that the spectrum of chemicals detected in the SENCAR mouse may be broadened using a combined bioassay that examines both lung and skin responses.
format Text
id pubmed-1474240
institution National Center for Biotechnology Information
language English
publishDate 1986
record_format MEDLINE/PubMed
spelling pubmed-14742402006-06-09 A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols. Robinson, M Bull, R J Knutsen, G L Shields, R P Stober, J Environ Health Perspect Research Article To test the feasibility of employing a combined lung adenoma/skin papilloma assay for broader detection of chemical carcinogenesis than that realized with either bioassay done separately, four strains of mice, SENCAR, BALB/c, A/J, and ICR-Swiss, were administered carcinogens either by the oral or intraperitoneal (IP) routes. The carcinogens administered were ethyl carbamate (EC), benzo(a)pyrene [B(a)P], N-[4-(5-nitro-2-furyl)thiazolyl]formamide (FANFT), and acrylamide (ACR). Starting 2 weeks later, 1 to 5 micrograms (depending on strain) of 12-O-tetradecanoylphorbol-13-acetate (TPA) in 0.2 mL acetone/mouse was applied three times weekly to the shaved back for 20 weeks. All strains displayed increases in the yield of lung adenomas in response to EC at 32 weeks. B(a)P increased lung adenomas in only the SENCAR and A/J strain. Only the SENCAR and ICR-Swiss mice gave positive responses in the skin. In the SENCAR mice, positive response was seen with all four chemicals, however, FANFT gave an inconsistent response. The ICR-Swiss mice responded with an increased skin papilloma yield only to EC. In a separate experiment involving only SENCAR mice, animals were treated with a single oral dose of diethylnitrosamine (DEN) followed by triweekly application of 1.0 microgram TPA. This treatment resulted in 51/57 animals developing lung adenomas vs. 5/57 in the control animals. No treatment-related skin tumors resulted with DEN. Histopathologically confirmed lesions indicate that the spectrum of chemicals detected in the SENCAR mouse may be broadened using a combined bioassay that examines both lung and skin responses. 1986-09 /pmc/articles/PMC1474240/ /pubmed/3780626 Text en
spellingShingle Research Article
Robinson, M
Bull, R J
Knutsen, G L
Shields, R P
Stober, J
A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols.
title A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols.
title_full A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols.
title_fullStr A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols.
title_full_unstemmed A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols.
title_short A combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols.
title_sort combined carcinogen bioassay utilizing both the lung adenoma and skin papilloma protocols.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1474240/
https://www.ncbi.nlm.nih.gov/pubmed/3780626
work_keys_str_mv AT robinsonm acombinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols
AT bullrj acombinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols
AT knutsengl acombinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols
AT shieldsrp acombinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols
AT stoberj acombinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols
AT robinsonm combinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols
AT bullrj combinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols
AT knutsengl combinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols
AT shieldsrp combinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols
AT stoberj combinedcarcinogenbioassayutilizingboththelungadenomaandskinpapillomaprotocols